loder
Start Typing

Here, you can select the report, if matching with your text

Cystic Fibrosis Therapeutics Market Size, Share, Forecast 2031

Cystic Fibrosis Therapeutics Market - By Drug Class: CFTR Modulators, Bronchodilators, Mucolytics, Antibiotics; By Age Group: Pediatric, Adult; By Region: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa

Report Code
CVMI24071656
Published
July 16, 2024
Last Updated
July 16, 2024
Coverage
Healthcare • Pharma
Buy Report Choose license • from $3600.00 Speak To An Analyst
Analyst-led, consultative delivery
Enterprise-ready licensing options
Fast turnarounds for custom cuts

Market Snapshot

High-signal KPIs designed for executive scanning.
Indicative snapshot. Request sample for full model outputs.
Market Size (latest)
—
— vs. prior year
CAGR
—
Forecast window: —
Forecast Period
2024–2031
Base years: 2019–2023
Coverage Depth
—
Segments • Regions • Players

Insights

Consultative narrative + actionable decision support.

The Cystic Fibrosis Therapeutics Market is experiencing significant growth, fueled by advancements in gene therapy, the development of CFTR modulators, and rising investment in precision medicine. Valued at USD 11.21 billion in 2023, the market is expected to grow at a CAGR of 14.75% from 2024 to 2031, ultimately reaching USD 33.69 billion by 2031.

Key Market Insights

Cystic fibrosis (CF) is a genetic disorder that affects the lungs and digestive system. It requires long-term treatment through pulmonary therapies, enzyme replacement, and emerging gene-editing technologies. The demand for targeted therapies and breakthrough CF drugs is increasing globally.

Growth Drivers

  • Advancements in CFTR Modulator Therapies: The introduction of triple-combination CFTR modulators is revolutionizing treatment outcomes.
  • Growing Investment in Gene Editing & RNA-Based CF Therapies – Research in CRISPR-Cas9 and RNA-based treatments is expanding therapeutic options.
  • Increased Adoption of Personalized and Precision Medicine Approaches – The emphasis on mutation-specific CF therapies is enhancing patient care outcomes.
  • Expanding the availability of CF care and multidisciplinary treatment centers—enhanced disease management strategies and specialized CF clinics are improving access to healthcare treatments.

 

Regional Trends

  • North America leads due to strong biotech research and FDA approvals for novel CF therapies.
  • Europe is expanding with government support for rare disease drug development.
  • Asia-Pacific is witnessing rapid growth, driven by increasing CF awareness and healthcare infrastructure improvements.
  • Latin America & MEA are emerging markets benefiting from international CF treatment collaborations.

 

Analyst View:

The Cystic Fibrosis Therapeutics Market is set for continuous expansion, driven by gene therapy breakthroughs, CFTR modulator advancements, and increasing funding for rare disease treatment research. Companies investing in personalized CF therapies, AI-driven drug development, and regenerative medicine applications will dominate this evolving sector.

Unlock the executive summary.
Request the sample to review key questions answered.
See what’s included.
Request sample for scope, definitions and segmentation.

Key Players

  • Vertex Pharmaceuticals Incorporated
  • AbbVie Inc.
  • Gilead Sciences
  • Inc.
  • Novartis AG
  • Viatris Inc.
Competitive Dashboard Preview
Shortlist strategic accounts and benchmark positioning.
Loading…
Request Competitive Cut

Segmentation Explorer

Interactively explore markets by segment and geography.
Refine View
—
Request A Custom Cut
Opportunity Index
Directional signals for prioritization and scenario framing.
Interactive
Need a board-ready slide? .
Modeling inputs: analyst assumptions, secondary sources, triangulated validations.

Table Of Contents

Expandable preview of coverage and chapter structure.

 

Cystic Fibrosis Therapeutics Market Report

  1. 1. Cystic Fibrosis Therapeutics Market Research Report
    1. 1.1 Study Objectives
    2. 1.2 Cystic Fibrosis Therapeutics Market - Overview
    3. 1.3 Reason to Read This Report
    4. 1.4 Methodology and Forecast Analysis
    2. Cystic Fibrosis Therapeutics Market Research Report - Preface
    1. 2.1 Cystic Fibrosis Therapeutics Market Research Report – Detailed Scope and Definitions
      1. 2.1.1 By Drug Class
      2. 2.1.2 By Age Group
      3. 2.1.3 By Region
    3. Cystic Fibrosis Therapeutics Market Dynamics
    1. 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
    2. 3.2. Restraints – By Drug Class, By Age Group, By Country
    3. 3.3. Opportunities – By Drug Class, By Age Group, By Country
    4. 3.4. Trends – By Drug Class, By Age Group, By Country
    5. 3.5. PEST Analysis
    6. 3.6. Porters Five Rule Analysis
    7. 3.7. Company’s Share Analysis (CSA) by Region or By Country
    8. 3.8. Cystic Fibrosis Therapeutics Market Research Report – DROTs Impact Analysis
    4. Cystic Fibrosis Therapeutics Market Research Report, Historic Data 2019 - 2023 and Forecast Analysis Data 2024 - 2031
    1. 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    2. 4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%)
    3. 4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
    4. 4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    5. Cystic Fibrosis Therapeutics Market, By Drug Class, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 5.1 CFTR Modulators
      1. 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 5.2 Bronchodilators
      1. 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    3. 5.3 Mucolytics
      1. 5.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 5.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 5.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 5.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    4. 5.4 Antibiotics
      1. 5.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 5.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 5.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 5.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. Cystic Fibrosis Therapeutics Market, By Age Group, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 6.1 Pediatric
      1. 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 6.2 Adult
      1. 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    7. Cystic Fibrosis Therapeutics Market Forecast, By Region, 2019 - 2023 and 2024 - 2031 (Market Value, In USD Mn)
    1. 7.1 North America
      1. 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 7.2 Europe
      1. 7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    3. 7.3 Asia-Pacific
      1. 7.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    4. 7.4 Latin America
      1. 7.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    5. 7.5 Middle East & Africa
      1. 7.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. 7.6 Cystic Fibrosis Therapeutics Market - Opportunity Analysis Index, By Drug Class, By Age Group, and Region, 2024 - 2031
    8. North America Cystic Fibrosis Therapeutics Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 8.1 By Drug Class Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 8.1.1 CFTR Modulators
      2. 8.1.2 Bronchodilators
      3. 8.1.3 Mucolytics
      4. 8.1.4 Antibiotics
      8.2 By Age Group Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 8.2.1 Pediatric
      2. 8.2.2 Adult
      8.3 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 8.3.1 United States
      2. 8.3.2 Canada
      8.4 North America Cystic Fibrosis Therapeutics Market – Opportunity Analysis Index, By Drug Class, By Age Group, and Country, 2024 - 2031
      8.5 Regional Trends Analysis
      8.6 North America Cystic Fibrosis Therapeutics Market Research Report - Company Profiles
      1. 8.6.1 Company 1 (United States)
      2. 8.6.2 Company 2 (Canada)
      3. 8.6.3 Company 3 (Canada)
    9. Europe Cystic Fibrosis Therapeutics Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 9.1 By Drug Class Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.1.1 CFTR Modulators
      2. 9.1.2 Bronchodilators
      3. 9.1.3 Mucolytics
      4. 9.1.4 Antibiotics
      9.2 By Age Group Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.2.1 Pediatric
      2. 9.2.2 Adult
      9.3 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.3.1 Germany
      2. 9.3.2 United Kingdom
      3. 9.3.3 France
      4. 9.3.4 Spain
      5. 9.3.5 Italy
      6. 9.3.6 Russia
      7. 9.3.7 Netherlands
      8. 9.3.8 Poland
      9. 9.3.9 Rest of Europe
      9.4 Europe Cystic Fibrosis Therapeutics Market – Opportunity Analysis Index, By Drug Class, By Age Group, and Country, 2024 - 2031
      9.5 Regional Trends Analysis
      9.6 Europe Cystic Fibrosis Therapeutics Market Research Report - Company Profiles
      1. 9.6.1 Company 1 (Germany)
      2. 9.6.2 Company 2 (United Kingdom)
      3. 9.6.3 Company 3 (United Kingdom)
    10. Asia-Pacific Cystic Fibrosis Therapeutics Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 10.1 By Drug Class Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.1.1 CFTR Modulators
      2. 10.1.2 Bronchodilators
      3. 10.1.3 Mucolytics
      4. 10.1.4 Antibiotics
      10.2 By Age Group Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.2.1 Pediatric
      2. 10.2.2 Adult
      10.3 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.3.1 China
      2. 10.3.2 Japan
      3. 10.3.3 India
      4. 10.3.4 South Korea
      5. 10.3.5 Australia & NZ
      6. 10.3.6 ASEAN
      7. 10.3.7 Rest of Asia-Pacific
      10.4 Asia-Pacific Cystic Fibrosis Therapeutics Market – Opportunity Analysis Index, By Drug Class, By Age Group, and Country, 2024 - 2031
      10.5 Regional Trends Analysis
      10.6 Asia-Pacific Cystic Fibrosis Therapeutics Market Research Report - Company Profiles
      1. 10.6.1 Company 1 (China)
      2. 10.6.2 Company 2 (Japan)
      3. 10.6.3 Company 3 (Japan)
    11. Latin America Cystic Fibrosis Therapeutics Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 11.1 By Drug Class Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.1.1 CFTR Modulators
      2. 11.1.2 Bronchodilators
      3. 11.1.3 Mucolytics
      4. 11.1.4 Antibiotics
      11.2 By Age Group Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.2.1 Pediatric
      2. 11.2.2 Adult
      11.3 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.3.1 Brazil
      2. 11.3.2 Mexico
      3. 11.3.3 Argentina
      4. 11.3.4 Peru
      5. 11.3.5 Colombia
      6. 11.3.6 Rest of Latin America
      11.4 Latin America Cystic Fibrosis Therapeutics Market – Opportunity Analysis Index, By Drug Class, By Age Group, and Country, 2024 - 2031
      11.5 Regional Trends Analysis
      11.6 Latin America Cystic Fibrosis Therapeutics Market Research Report - Company Profiles
      1. 11.6.1 Company 1 (Brazil)
      2. 11.6.2 Company 2 (Mexico)
      3. 11.6.3 Company 3 (Mexico)
    12. Middle East & Africa Cystic Fibrosis Therapeutics Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 12.1 By Drug Class Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.1.1 CFTR Modulators
      2. 12.1.2 Bronchodilators
      3. 12.1.3 Mucolytics
      4. 12.1.4 Antibiotics
      12.2 By Age Group Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.2.1 Pediatric
      2. 12.2.2 Adult
      12.3 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.3.1 Saudi Arabia
      2. 12.3.2 UAE
      3. 12.3.3 South Africa
      4. 12.3.4 Egypt
      5. 12.3.5 Israel
      6. 12.3.6 Rest of Middle East and Africa
      12.4 Middle East & Africa Cystic Fibrosis Therapeutics Market – Opportunity Analysis Index, By Drug Class, By Age Group, and Country, 2024 - 2031
      12.5 Regional Trends Analysis
      12.6 Middle East & Africa Cystic Fibrosis Therapeutics Market Research Report - Company Profiles
      1. 12.6.1 Company 1 (Saudi Arabia)
      2. 12.6.2 Company 2 (UAE)
      3. 12.6.3 Company 3 (UAE)
    13. Competition Landscape
    1. 13.1 Strategic Dashboard of Top Market Players
      13.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)
      1. 13.2.1 Vertex Pharmaceuticals Incorporated
      2. 13.2.2 AbbVie Inc.
      3. 13.2.3 Gilead Sciences
      4. 13.2.4 Inc.
      5. 13.2.5 Novartis AG
      6. 13.2.6 Viatris Inc.
    14. Data Collection Method and Research Approach
    15. Principal Presumptions and Acronyms

Methodology & Credibility

Built for enterprise decisions, not vanity metrics.
Triangulated Sizing
Bottom-up, top-down, and peer benchmarks reconciled by analysts.
Primary + Secondary Research
Executive interviews combined with validated public and paid sources.
Scenario & Sensitivity
Base, bull and bear cases to stress-test strategic moves.
Need Confidence Fast?
We’ll map your questions to the report in 15 minutes.
Book A Consultation
Preferred by strategy, marketing, and corporate development teams.

Related Reports

More coverage in adjacent themes and segments.
Global Glioma Diagnosis and Treatment Market & Competitive Intelligence, 2019 to 2024, Forecast 2025 to 2031 Research Report
CVMI24071660 Jan. 30, 2026
$3600.00 single user
View report →
Global LED Lip Masks Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report
CVMI30115 Dec. 1, 2025
$3600.00 single user
View report →
Global Advanced Musculoskeletal Care Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report
CVMI30116 Dec. 1, 2025
$3600.00 single user
View report →
Global Under-Arm Exoskeletons Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report
CVMI0112 Dec. 1, 2025
$3600.00 single user
View report →
Global Wearable Light Therapy Devices Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report
CVMI30112 Nov. 30, 2025
$3600.00 single user
View report →
Global Light-Powered Joint Support Systems Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report
CVMI30114 Nov. 30, 2025
$3600.00 single user
View report →
Global Wearable Medical-Grade Cold Lasers Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report
CVMI3011 Nov. 30, 2025
$3600.00 single user
View report →
Global Dual Microcurrent Devices Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report
CVMI30113 Nov. 30, 2025
$3600.00 single user
View report →
Global Wearable Light-Emitting Diodes (LEDs) Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report
CVMI27111 Nov. 27, 2025
$3600.00 single user
View report →
Global Targeted Air Compression Therapies Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report
CVMI2711 Nov. 27, 2025
$3600.00 single user
View report →
Global Robotic Hand Assistance Solutions Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report
CVMI2611 Nov. 26, 2025
$3600.00 single user
View report →
Istanbul Hair Transplant Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report
CVMI26081 Aug. 26, 2025
$3600.00 single user
View report →
Ready to move from data to decision?
Get the report, request a sample, or book a consultative briefing.
Buy Report Talk To An Analyst
New chat message received
×

Need help?

Chat with our team in a minute.
We usually reply within a few minutes.